Mental health conditions continue to defy available treatment options, but Aditum Bio is hoping to rise to the challenge with a new biotech that will take another look at Taisho Pharmaceutical's ...

Venture capital firm Aditum Bio is going all-out for a new collaboration with Fosun Pharma, launching a subsidiary with the sole purpose of developing novel therapies in tandem with the Shanghai-based ...

OAKLAND, Calif., June 30, 2021 /PRNewswire/ -- Aditum Bio, the biotech investment firm co-founded in 2019 by former Novartis CEO Joe Jimenez and former President of the Novartis Institutes for ...

China’s Mabwell Bioscience and US-based Aditum Bio have launched Kalexo Bio, a new company, to develop a new small interfering RNA (siRNA) candidate, 2MW7141. The initiative follows an exclusive ...

Celexor Bio expected to focus on ell depletion of pathologic cells in autoimmune and inflammatory disorders. Immagene Biopharmaceuticals and Aditum Bio have announced a joint venture to create Celexor ...

Joe Jimenez, best known in biopharma as the ex-CEO of Novartis, has spent the last year-plus starting up something entirely different: a biotech investment firm focused on drug candidates that have ...

NORWALK, Conn.--(BUSINESS WIRE)--Aditum, known for its broadband infrastructure delivery platform giving building owners control over their telecom network in multi-tenant properties announces a ...